According to Latest Study , the global market for Acute Myeloid Leukemia Biomarker Detection should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Acute Myeloid Leukemia Biomarker Detection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Acute Myeloid Leukemia Biomarker Detection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Next Generation Sequencing Technology segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Acute Myeloid Leukemia Biomarker Detection include Abbott Laboratories, Bio-Rad Laboratories, Inc., Genmark Saghlk Orinleri, Laboratory Corporation of America Holdings, Danaher, Medaysis Company, NeoGenomics Laboratories, QIAGEN N.V. and Thermo Fisher Scientific, Inc., etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

Acute myeloid leukemia is a malignant neoplastic disease that usually results from the deterioration of stem cells in the bone marrow. Biomarker detection is a method that can detect specific molecular or genetic variations of leukemia cells, which can be used to diagnose AML, evaluate patient prognosis, and guide the selection of treatment options.

This report aims to provide a comprehensive study of the global market for Acute Myeloid Leukemia Biomarker Detection. Report Highlights:

(1) Global Acute Myeloid Leukemia Biomarker Detection market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Acute Myeloid Leukemia Biomarker Detection market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China Acute Myeloid Leukemia Biomarker Detection market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global Acute Myeloid Leukemia Biomarker Detection segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Acute Myeloid Leukemia Biomarker Detection segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Acute Myeloid Leukemia Biomarker Detection, capacity, production and trends.

(7) Acute Myeloid Leukemia Biomarker Detection industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Next Generation Sequencing Technology

PCR Detection Technology

Market segment by application, can be divided into

Hospital

Research Institutions

Other

Market segment by players, this report covers

Abbott Laboratories

Bio-Rad Laboratories, Inc.

Genmark Saghlk Orinleri

Laboratory Corporation of America Holdings

Danaher

Medaysis Company

NeoGenomics Laboratories

QIAGEN N.V.

Thermo Fisher Scientific, Inc.

GeneTex

1 Market Overview

1.1 Acute Myeloid Leukemia Biomarker Detection Definition

1.2 Global Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast

1.2.1 By Revenue, Global Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

1.2.2 By Sales Volume, Global Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

1.2.3 Global Acute Myeloid Leukemia Biomarker Detection Price Trend, 2019-2030

1.3 China Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast

1.3.1 By Revenue, China Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

1.3.2 By Sales Volume, China Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

1.3.3 China Acute Myeloid Leukemia Biomarker Detection Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Acute Myeloid Leukemia Biomarker Detection Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Acute Myeloid Leukemia Biomarker Detection Share in Global Market, 2019-2030

1.4.3 Acute Myeloid Leukemia Biomarker Detection Market Size: China VS Global, 2019-2030

1.5 Acute Myeloid Leukemia Biomarker Detection Market Dynamics

1.5.1 Acute Myeloid Leukemia Biomarker Detection Market Drivers

1.5.2 Acute Myeloid Leukemia Biomarker Detection Market Restraints

1.5.3 Acute Myeloid Leukemia Biomarker Detection Industry Trends

1.5.4 Acute Myeloid Leukemia Biomarker Detection Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Company, 2019-2024

2.2 Global Acute Myeloid Leukemia Biomarker Detection Sales Volume by Company, 2019-2024

2.3 Global Acute Myeloid Leukemia Biomarker Detection Price by Company, 2019-2024

2.4 Global Acute Myeloid Leukemia Biomarker Detection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Acute Myeloid Leukemia Biomarker Detection Concentration Ratio

2.6 Global Acute Myeloid Leukemia Biomarker Detection Mergers & Acquisitions, Expansion Plans

2.7 Global Acute Myeloid Leukemia Biomarker Detection Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Acute Myeloid Leukemia Biomarker Detection Revenue by Company, 2019-2024

3.2 China Acute Myeloid Leukemia Biomarker Detection Sales Volume by Company, 2019-2024

3.3 China Acute Myeloid Leukemia Biomarker Detection Acute Myeloid Leukemia Biomarker Detection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Acute Myeloid Leukemia Biomarker Detection Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, Acute Myeloid Leukemia Biomarker Detection Domestic VS Export

3.6 China Market, Acute Myeloid Leukemia Biomarker Detection Import & Export

3.6.1 China Market, Acute Myeloid Leukemia Biomarker Detection Import & Export, 2019-2030

3.6.2 China Acute Myeloid Leukemia Biomarker Detection Import & Export Trends

3.6.3 Main Sources of China Acute Myeloid Leukemia Biomarker Detection Import

3.6.4 Export Destination of China Acute Myeloid Leukemia Biomarker Detection

4 Acute Myeloid Leukemia Biomarker Detection Production by Region

4.1 Global Acute Myeloid Leukemia Biomarker Detection Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Acute Myeloid Leukemia Biomarker Detection Manufacturers

4.3 Global Major Manufacturers, Acute Myeloid Leukemia Biomarker Detection Capacity Expansion and Future Plans

4.4 Global Acute Myeloid Leukemia Biomarker Detection Capacity by Region

4.5 Global Acute Myeloid Leukemia Biomarker Detection Production by Region

4.5.1 Global Acute Myeloid Leukemia Biomarker Detection Production & Forecast by Region, 2019 VS 2023 VS 2030

4.5.2 Global Acute Myeloid Leukemia Biomarker Detection Production by Region, 2019-2024

4.5.3 Global Acute Myeloid Leukemia Biomarker Detection Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Acute Myeloid Leukemia Biomarker Detection Industry Chain

5.2 Acute Myeloid Leukemia Biomarker Detection Upstream Analysis

5.2.1 Acute Myeloid Leukemia Biomarker Detection Core Raw Materials

5.2.2 Main Manufacturers of Acute Myeloid Leukemia Biomarker Detection Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Acute Myeloid Leukemia Biomarker Detection Production Mode

5.6 Acute Myeloid Leukemia Biomarker Detection Procurement Model

5.7 Acute Myeloid Leukemia Biomarker Detection Industry Sales Model and Sales Channels

5.7.1 Acute Myeloid Leukemia Biomarker Detection Sales Model

5.7.2 Acute Myeloid Leukemia Biomarker Detection Typical Distributors

6 Sights by Type

6.1 Acute Myeloid Leukemia Biomarker Detection Classification

6.1.1 Next Generation Sequencing Technology

6.1.2 PCR Detection Technology

6.2 By Type, Global Acute Myeloid Leukemia Biomarker Detection Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Type, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030

6.4 By Type, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030

6.5 By Type, Global Acute Myeloid Leukemia Biomarker Detection Price, 2019-2030

7 Sights by Application

7.1 Acute Myeloid Leukemia Biomarker Detection Segment by Application

7.1.1 Hospital

7.1.2 Research Institutions

7.1.3 Other

7.2 By Application, Global Acute Myeloid Leukemia Biomarker Detection Market Size & CAGR, 2019 VS 2023 VS 2030

7.3 By Application, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030

7.4 By Application, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030

7.5 By Application, Global Acute Myeloid Leukemia Biomarker Detection Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Acute Myeloid Leukemia Biomarker Detection Market Size, 2019 VS 2023 VS 2030

8.2 By Region, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030

8.3 By Region, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Acute Myeloid Leukemia Biomarker Detection Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Acute Myeloid Leukemia Biomarker Detection Market Size Market Share

8.5 Europe

8.5.1 Europe Acute Myeloid Leukemia Biomarker Detection Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Acute Myeloid Leukemia Biomarker Detection Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Acute Myeloid Leukemia Biomarker Detection Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Acute Myeloid Leukemia Biomarker Detection Market Size Market Share

8.7 South America

8.7.1 South America Acute Myeloid Leukemia Biomarker Detection Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Acute Myeloid Leukemia Biomarker Detection Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Acute Myeloid Leukemia Biomarker Detection Market Size & CAGR，2019 VS 2023 VS 2030

9.2 By Country, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030

9.3 By Country, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

9.4.2 By Company, U.S. Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.4.4 By Application, U.S. Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.5 Europe

9.5.1 Europe Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

9.5.2 By Company, Europe Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022

9.5.3 By Type, Europe Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.5.4 By Application, Europe Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.6 China

9.6.1 China Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

9.6.2 By Company, China Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022

9.6.3 By Type, China Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.6.4 By Application, China Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.7 Japan

9.7.1 Japan Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

9.7.2 By Company, Japan Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022

9.7.3 By Type, Japan Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.7.4 By Application, Japan Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.8 South Korea

9.8.1 South Korea Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

9.8.2 By Company, South Korea Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.8.4 By Application, South Korea Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.9.4 By Application, Southeast Asia Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.10 India

9.10.1 India Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

9.10.2 By Company, India Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022

9.10.3 By Type, India Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.10.4 By Application, India Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

9.11.4 By Application, Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Market Size, Share, 2023 VS 2030

10 Manufacturers Profile

10.1 Abbott Laboratories

10.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

10.1.2 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.1.3 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Abbott Laboratories Company Profile and Main Business

10.1.5 Abbott Laboratories Recent Developments

10.2 Bio-Rad Laboratories, Inc.

10.2.1 Bio-Rad Laboratories, Inc. Company Information, Head Office, Market Area and Industry Position

10.2.2 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.2.3 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Bio-Rad Laboratories, Inc. Company Profile and Main Business

10.2.5 Bio-Rad Laboratories, Inc. Recent Developments

10.3 Genmark Saghlk Orinleri

10.3.1 Genmark Saghlk Orinleri Company Information, Head Office, Market Area and Industry Position

10.3.2 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.3.3 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Genmark Saghlk Orinleri Company Profile and Main Business

10.3.5 Genmark Saghlk Orinleri Recent Developments

10.4 Laboratory Corporation of America Holdings

10.4.1 Laboratory Corporation of America Holdings Company Information, Head Office, Market Area and Industry Position

10.4.2 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.4.3 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Laboratory Corporation of America Holdings Company Profile and Main Business

10.4.5 Laboratory Corporation of America Holdings Recent Developments

10.5 Danaher

10.5.1 Danaher Company Information, Head Office, Market Area and Industry Position

10.5.2 Danaher Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.5.3 Danaher Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Danaher Company Profile and Main Business

10.5.5 Danaher Recent Developments

10.6 Medaysis Company

10.6.1 Medaysis Company Company Information, Head Office, Market Area and Industry Position

10.6.2 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.6.3 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Medaysis Company Company Profile and Main Business

10.6.5 Medaysis Company Recent Developments

10.7 NeoGenomics Laboratories

10.7.1 NeoGenomics Laboratories Company Information, Head Office, Market Area and Industry Position

10.7.2 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.7.3 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 NeoGenomics Laboratories Company Profile and Main Business

10.7.5 NeoGenomics Laboratories Recent Developments

10.8 QIAGEN N.V.

10.8.1 QIAGEN N.V. Company Information, Head Office, Market Area and Industry Position

10.8.2 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.8.3 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 QIAGEN N.V. Company Profile and Main Business

10.8.5 QIAGEN N.V. Recent Developments

10.9 Thermo Fisher Scientific, Inc.

10.9.1 Thermo Fisher Scientific, Inc. Company Information, Head Office, Market Area and Industry Position

10.9.2 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.9.3 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Thermo Fisher Scientific, Inc. Company Profile and Main Business

10.9.5 Thermo Fisher Scientific, Inc. Recent Developments

10.10 GeneTex

10.10.1 GeneTex Company Information, Head Office, Market Area and Industry Position

10.10.2 GeneTex Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

10.10.3 GeneTex Acute Myeloid Leukemia Biomarker Detection Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.10.4 GeneTex Company Profile and Main Business

10.10.5 GeneTex Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Acute Myeloid Leukemia Biomarker Detection Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Acute Myeloid Leukemia Biomarker Detection Market Restraints

Table 3. Acute Myeloid Leukemia Biomarker Detection Market Trends

Table 4. Acute Myeloid Leukemia Biomarker Detection Industry Policy

Table 5. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Company, 2019-2024, US$ million

Table 6. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company, 2019-2024

Table 7. Global Acute Myeloid Leukemia Biomarker Detection Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share by Company, 2019-2024

Table 9. Global Acute Myeloid Leukemia Biomarker Detection Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Acute Myeloid Leukemia Biomarker Detection Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Acute Myeloid Leukemia Biomarker Detection Mergers & Acquisitions, Expansion Plans

Table 12. Global Acute Myeloid Leukemia Biomarker Detection Manufacturers Product Type

Table 13. China Acute Myeloid Leukemia Biomarker Detection Revenue by Company, 2019-2024, US$ million

Table 14. China Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company, 2019-2024

Table 15. China Acute Myeloid Leukemia Biomarker Detection Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Acute Myeloid Leukemia Biomarker Detection Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Acute Myeloid Leukemia Biomarker Detection Import & Export Trends

Table 19. Main Sources of China Acute Myeloid Leukemia Biomarker Detection Import

Table 20. Export Destination of China Acute Myeloid Leukemia Biomarker Detection

Table 21. Global Headquarters and Manufacturing Base of Acute Myeloid Leukemia Biomarker Detection Manufacturers

Table 22. Global Major Manufacturers, Acute Myeloid Leukemia Biomarker Detection Capacity Expansion and Future Plans

Table 23. Global Acute Myeloid Leukemia Biomarker Detection Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Acute Myeloid Leukemia Biomarker Detection Production by Region, 2019-2024, (K Units)

Table 25. Global Acute Myeloid Leukemia Biomarker Detection Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Acute Myeloid Leukemia Biomarker Detection Upstream (Raw Materials)

Table 27. Global Acute Myeloid Leukemia Biomarker Detection Typical Customers

Table 28. Acute Myeloid Leukemia Biomarker Detection Typical Distributors

Table 29. By Type, Global Acute Myeloid Leukemia Biomarker Detection Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Acute Myeloid Leukemia Biomarker Detection Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Acute Myeloid Leukemia Biomarker Detection Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Acute Myeloid Leukemia Biomarker Detection Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2019-2030

Table 37. By Country, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2019-2030

Table 39. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 40. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 41. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Abbott Laboratories Company Profile and Main Business

Table 43. Abbott Laboratories Recent Developments

Table 44. Bio-Rad Laboratories, Inc. Company Information, Head Office, Market Area and Industry Position

Table 45. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 46. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Bio-Rad Laboratories, Inc. Company Profile and Main Business

Table 48. Bio-Rad Laboratories, Inc. Recent Developments

Table 49. Genmark Saghlk Orinleri Company Information, Head Office, Market Area and Industry Position

Table 50. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 51. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Genmark Saghlk Orinleri Company Profile and Main Business

Table 53. Genmark Saghlk Orinleri Recent Developments

Table 54. Laboratory Corporation of America Holdings Company Information, Head Office, Market Area and Industry Position

Table 55. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 56. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Laboratory Corporation of America Holdings Company Profile and Main Business

Table 58. Laboratory Corporation of America Holdings Recent Developments

Table 59. Danaher Company Information, Head Office, Market Area and Industry Position

Table 60. Danaher Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 61. Danaher Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Danaher Company Profile and Main Business

Table 63. Danaher Recent Developments

Table 64. Medaysis Company Company Information, Head Office, Market Area and Industry Position

Table 65. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 66. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Medaysis Company Company Profile and Main Business

Table 68. Medaysis Company Recent Developments

Table 69. NeoGenomics Laboratories Company Information, Head Office, Market Area and Industry Position

Table 70. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 71. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. NeoGenomics Laboratories Company Profile and Main Business

Table 73. NeoGenomics Laboratories Recent Developments

Table 74. QIAGEN N.V. Company Information, Head Office, Market Area and Industry Position

Table 75. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 76. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. QIAGEN N.V. Company Profile and Main Business

Table 78. QIAGEN N.V. Recent Developments

Table 79. Thermo Fisher Scientific, Inc. Company Information, Head Office, Market Area and Industry Position

Table 80. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 81. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Thermo Fisher Scientific, Inc. Company Profile and Main Business

Table 83. Thermo Fisher Scientific, Inc. Recent Developments

Table 84. GeneTex Company Information, Head Office, Market Area and Industry Position

Table 85. GeneTex Acute Myeloid Leukemia Biomarker Detection Models, Specifications and Application

Table 86. GeneTex Acute Myeloid Leukemia Biomarker Detection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. GeneTex Company Profile and Main Business

Table 88. GeneTex Recent Developments

List of Figure

Figure 1. Acute Myeloid Leukemia Biomarker Detection Picture

Figure 2. By Revenue, Global Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Acute Myeloid Leukemia Biomarker Detection Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Acute Myeloid Leukemia Biomarker Detection Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Acute Myeloid Leukemia Biomarker Detection Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Acute Myeloid Leukemia Biomarker Detection Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Acute Myeloid Leukemia Biomarker Detection Share of Global Market, 2019-2030

Figure 10. Global Acute Myeloid Leukemia Biomarker Detection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Acute Myeloid Leukemia Biomarker Detection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Acute Myeloid Leukemia Biomarker Detection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Acute Myeloid Leukemia Biomarker Detection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Acute Myeloid Leukemia Biomarker Detection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Acute Myeloid Leukemia Biomarker Detection Domestic VS Export, 2022

Figure 16. Global Acute Myeloid Leukemia Biomarker Detection Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Acute Myeloid Leukemia Biomarker Detection Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Acute Myeloid Leukemia Biomarker Detection Production Market Share & Forecast by Region, 2019-2030

Figure 19. Acute Myeloid Leukemia Biomarker Detection Industry Chain

Figure 20. Acute Myeloid Leukemia Biomarker Detection Procurement Model

Figure 21. Acute Myeloid Leukemia Biomarker Detection Sales Model

Figure 22. Acute Myeloid Leukemia Biomarker Detection Sales Channels, Direct Sales and Distribution

Figure 23. Next Generation Sequencing Technology

Figure 24. PCR Detection Technology

Figure 25. By Type, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2019-2030

Figure 27. By Type, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Acute Myeloid Leukemia Biomarker Detection Price, 2019-2030, (US$/Unit)

Figure 30. Hospital

Figure 31. Research Institutions

Figure 32. Other

Figure 33. By Application, Global Acute Myeloid Leukemia Biomarker Detection Revenue, 2019-2030, US$ Million

Figure 34. By Application, Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2019-2030

Figure 35. By Application, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 36. By Application, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2019-2030

Figure 37. By Application, Global Acute Myeloid Leukemia Biomarker Detection Price, 2019-2030, (US$/Unit)

Figure 38. By Region, Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2019-2030

Figure 39. By Region, Global Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2019-2030

Figure 40. North America Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, North America Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2022

Figure 42. Europe Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, Europe Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2022

Figure 44. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country/Region, Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2022

Figure 46. South America Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, South America Acute Myeloid Leukemia Biomarker Detection Revenue Market Share, 2022

Figure 48. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. U.S. Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 50. By Company, U.S. Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 51. By Type, U.S. Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 52. By Application, U.S. Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 53. Europe Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, Europe Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 55. By Type, Europe Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, Europe Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 57. China Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, China Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 59. By Type, China Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, China Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 61. Japan Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, Japan Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 63. By Type, Japan Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, Japan Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 65. South Korea Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, South Korea Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 67. By Type, South Korea Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, South Korea Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 69. Southeast Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, Southeast Asia Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 71. By Type, Southeast Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, Southeast Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 73. India Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, India Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 75. By Type, India Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, India Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 77. Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Market Share, 2022

Figure 79. By Type, Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application, Middle East & Asia Acute Myeloid Leukemia Biomarker Detection Sales Volume Market Share, 2022 VS 2029

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)